Mirabaud Asset Management »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Mirabaud Asset Management

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Mirabaud Asset Management from 13F filings

Historical chart of Mirabaud Asset Management investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Mirabaud Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Mirabaud Asset Management

Quarter filed Position value Share count Share price at filing
2025-06-30 $8.9B 7.8M 1146.02

More positions owned by Mirabaud Asset Management

Nextera Energy Cap Hldgs Note 3.000% 3/0 (Principal)
Global Pmts Note 1.500% 3/0 (Principal)
Coinbase Global Note 0.250% 4/0 (Principal)
Halozyme Therapeutics Note 1.000% 8/1 (Principal)
American Wtr Cap Corp Note 3.625% 6/1 (Principal)
Dropbox Note 3/0 (Principal)
Rivian Automotive Note 4.625% 3/1 (Principal)
Middleby Corp Note 1.000% 9/0 (Principal)
Li Auto Note 0.250% 5/0 (Principal)
Liberty Media Corp Del Note 2.250% 8/1 (Principal)
On Semiconductor Corp Note 5/0 (Principal)

View all positions for Mirabaud Asset Management

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

Millennium Management
LMR Partners
Calamos Advisors
Camden Asset Management
Balyasny Asset Management
DLD Asset Management
Point72 Asset Management
Davidson Kempner Capital Management
Jpmorgan Chase & Co
Jain Global
Nuveen
Lazard Asset Management
State Street Corporation
Absolute Investment Advisers
Citadel Advisors

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1